Table 3.
Variable | Nonadjusted (HR (95% CI), P) | Adjusted I (HR (95% CI), P) | Adjusted II (HR (95% CI), P) |
---|---|---|---|
30-day SII (quartile) | |||
Q1 | 1 (Ref) | 1 (Ref) | 1 (Ref) |
Q2 | 1.03 (0.63–1.67), 0.91 | 1.08 (0.66–1.75) 0.765 | 1.3 (0.79–2.12) 0.297 |
Q3 | 1.42 (0.91–2.21), 0.123 | 1.61 (1.03–2.51) 0.037 | 1.86 (1.18–2.93) 0.007 |
Q4 | 2.28 (1.51–3.43), <0.001 | 2.56 (1.69–3.86) <0.001 | 2.72 (1.78–4.17) <0.001 |
Log SII | 2.35 (1.63–3.37), <0.001 | 2.51 (1.76–3.59) <0.001 | 2.43 (1.71–3.45) <0.001 |
| |||
90-day SII (quartile) | |||
Q1 | 1 (Ref) | 1 (Ref) | 1 (Ref) |
Q2 | 1 (0.63–1.58), 0.99 | 1.04 (0.65–1.65), 0.884 | 1.25 (0.78–2), 0.355 |
Q3 | 1.45 (0.95–2.21), 0.081 | 1.68 (1.1–2.57), 0.016 | 1.87 (1.22–2.87), 0.004 |
Q4 | 2.14 (1.44–3.17), <0.001 | 2.45 (1.65–3.64), <0.001 | 2.63 (1.74–3.96), <0.001 |
Log SII | 2 (1.56–3.11), <0.001 | 2.42 (1.72–3.41), <0.001 | 1.92 (1.36–2.72), <0.001 |
P for trend | <0.001 | <0.001 | <0.001 |
Nonadjusted: no covariates were adjusted; adjusted I: we only adjusted for age and sex; adjusted II: we adjusted for age, gender, heart rate, respiratory rate, Charlson comorbidity, anion gap, bicarbonate, glucose, warfarin, NOAC, antiplatelet agents, PEGJ, mechanical ventilation, SOFA, and LOS.ICU. HR, hazard ratio; CI, confidence interval; Ref, reference.